Showing results (191-200 of 413) with videos related to

Sort By:
Pageof 42
Journal of the National Cancer Institute|August 17, 2006
Effect of finasteride on the sensitivity of PSA for detecting prostate cancerIan M Thompson, Chen Chi, Donna Pauler Ankerst, et al.
Carcinogenesis|June 12, 2008
CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic CaucasiansJoke Beuten, Jonathan A L Gelfond, John J Byrne, et al.
RSC Advances|June 23, 2015
Enhancement of performance in porous bead-based microchip sensors: Effects of chip geometry on bio-agent captureEliona Kulla, Jie Chou, Glennon Simmons, et al.
The Prostate|July 29, 2014
Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancerPawel Osmulski, Devalingam Mahalingam, Maria E Gaczynska, et al.
Frontiers in Oncology|January 31, 2022
Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialZhihong Gong, Mary E Platek, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 6, 2009
Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trialElizabeth A Platz, Cathee Till, Phyllis J Goodman, et al.
Urology|February 22, 2011
Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032David C Smith, Cathy M Tangen, Peter J Van Veldhuizen, et al.
Cancer Research|April 19, 2006
Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridizationSapna Vijayakumar, Devon C Hall, Xavier T Reveles, et al.
Prostate Cancer and Prostatic Diseases|November 3, 2018
Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR studyMichael A Liss, Osamah Al-Bayati, Jonathan Gelfond, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107Przemyslaw W Twardowski, Catherine M Tangen, Xiwei Wu, et al.
Pageof 42